Annual Shareholders Equity
$83.47 M
-$98.05 M-54.02%
31 December 2023
Summary:
Adverum Biotechnologies annual stockholders equity is currently $83.47 million, with the most recent change of -$98.05 million (-54.02%) on 31 December 2023. During the last 3 years, it has fallen by -$350.88 million (-80.78%). ADVM annual shareholders equity is now -80.78% below its all-time high of $434.35 million, reached on 31 December 2020.ADVM Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$144.12 M
-$23.91 M-14.23%
30 September 2024
Summary:
Adverum Biotechnologies quarterly stockholders equity is currently $144.12 million, with the most recent change of -$23.91 million (-14.23%) on 30 September 2024. Over the past year, it has increased by +$41.40 million (+40.31%). ADVM quarterly shareholders equity is now -68.99% below its all-time high of $464.71 million, reached on 30 September 2020.ADVM Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADVM Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.0% | +40.3% |
| 3 y3 years | -80.8% | -58.4% |
| 5 y5 years | -58.5% | -12.2% |
ADVM Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -80.8% | at low | -58.4% | +72.7% |
| 5 y | 5 years | -80.8% | at low | -69.0% | +72.7% |
| alltime | all time | -80.8% | +8472.0% | -69.0% | >+9999.0% |
Adverum Biotechnologies Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $144.12 M(-14.2%) |
| June 2024 | - | $168.03 M(-7.8%) |
| Mar 2024 | - | $182.29 M(+118.4%) |
| Dec 2023 | $83.47 M(-54.0%) | $83.47 M(-18.7%) |
| Sept 2023 | - | $102.71 M(-21.7%) |
| June 2023 | - | $131.16 M(-16.9%) |
| Mar 2023 | - | $157.76 M(-13.1%) |
| Dec 2022 | $181.52 M(-42.6%) | $181.52 M(-12.9%) |
| Sept 2022 | - | $208.34 M(-14.7%) |
| June 2022 | - | $244.12 M(-13.7%) |
| Mar 2022 | - | $282.95 M(-10.5%) |
| Dec 2021 | $316.19 M(-27.2%) | $316.19 M(-8.6%) |
| Sept 2021 | - | $346.00 M(-8.7%) |
| June 2021 | - | $379.14 M(-8.6%) |
| Mar 2021 | - | $414.82 M(-4.5%) |
| Dec 2020 | $434.35 M(+148.3%) | $434.35 M(-6.5%) |
| Sept 2020 | - | $464.71 M(+64.5%) |
| June 2020 | - | $282.56 M(-7.0%) |
| Mar 2020 | - | $303.95 M(+73.7%) |
| Dec 2019 | $174.96 M | $174.96 M(+6.5%) |
| Sept 2019 | - | $164.21 M(-7.6%) |
| June 2019 | - | $177.74 M(-5.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $188.14 M(-6.5%) |
| Dec 2018 | $201.17 M(+9.3%) | $201.17 M(-6.7%) |
| Sept 2018 | - | $215.55 M(-7.7%) |
| June 2018 | - | $233.45 M(-5.1%) |
| Mar 2018 | - | $246.04 M(+33.7%) |
| Dec 2017 | $184.03 M(-14.6%) | $184.03 M(+1.7%) |
| Sept 2017 | - | $180.99 M(-5.8%) |
| June 2017 | - | $192.18 M(-4.6%) |
| Mar 2017 | - | $201.38 M(-6.6%) |
| Dec 2016 | $215.60 M(-14.6%) | $215.60 M(-8.7%) |
| Sept 2016 | - | $236.23 M(-4.6%) |
| June 2016 | - | $247.65 M(+2.5%) |
| Mar 2016 | - | $241.57 M(-4.4%) |
| Dec 2015 | $252.59 M(+69.0%) | $252.59 M(-3.7%) |
| Sept 2015 | - | $262.33 M(-3.1%) |
| June 2015 | - | $270.63 M(-3.2%) |
| Mar 2015 | - | $279.68 M(+87.1%) |
| Dec 2014 | $149.48 M(<-9900.0%) | $149.48 M(-4.0%) |
| Sept 2014 | - | $155.74 M(+261.9%) |
| June 2014 | - | $43.04 M(-13.8%) |
| Mar 2014 | - | $49.91 M(<-9900.0%) |
| Dec 2013 | -$218.00 K(-78.1%) | -$218.00 K |
| Dec 2012 | -$997.00 K | - |
FAQ
- What is Adverum Biotechnologies annual stockholders equity?
- What is the all time high annual shareholders equity for Adverum Biotechnologies?
- What is Adverum Biotechnologies annual shareholders equity year-on-year change?
- What is Adverum Biotechnologies quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Adverum Biotechnologies?
- What is Adverum Biotechnologies quarterly shareholders equity year-on-year change?
What is Adverum Biotechnologies annual stockholders equity?
The current annual shareholders equity of ADVM is $83.47 M
What is the all time high annual shareholders equity for Adverum Biotechnologies?
Adverum Biotechnologies all-time high annual stockholders equity is $434.35 M
What is Adverum Biotechnologies annual shareholders equity year-on-year change?
Over the past year, ADVM annual stockholders equity has changed by -$98.05 M (-54.02%)
What is Adverum Biotechnologies quarterly stockholders equity?
The current quarterly shareholders equity of ADVM is $144.12 M
What is the all time high quarterly shareholders equity for Adverum Biotechnologies?
Adverum Biotechnologies all-time high quarterly stockholders equity is $464.71 M
What is Adverum Biotechnologies quarterly shareholders equity year-on-year change?
Over the past year, ADVM quarterly stockholders equity has changed by +$41.40 M (+40.31%)